Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maeve A Hennessy

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Anti-Cancer Drugs|December 10, 2019
Induction treatment prior to chemoradiotherapy in nasopharyngeal carcinoma: triplet or doublet chemotherapy?Maeve A Hennessy, Patrick G Morris
Annals of Palliative Medicine|April 3, 2020
Optimizing Anti-HER2 Therapy in early breast cancer: updates from the KRISTINE trialMaeve A Hennessy, Patrick G Morris
Irish Journal of Medical Science|April 6, 2024
Dietary supplement beliefs and use patterns among Irish patients with early-stage breast cancerEimear O'Donovan, Maeve A Hennessy, Seamus O'Reilly
Expert Opinion on Investigational Drugs|February 7, 2026
Triple negative breast cancer: what clinical progress have we seen in the last 5 years?Daniel S Peiffer, Maeve A Hennessy, Rita Nanda
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 2, 2024
Charting cancer's course: revealing the role of diet, exercise, and the microbiome in cancer evolution and immunotherapy responseAna Isabel Martin-Quesada, Maeve A Hennessy, Ana Cardeña Gutiérrez
JAMA Network Open|April 23, 2026
Disparities in Disease Presentation and Treatment Initiation for De Novo Metastatic Breast CancerJincong Q Freeman, Apoorva Ravichandran, Sarah Poland, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 16, 2026
Personalizing Curative Therapy in Stage II to III Triple-Negative Breast CancerAlexis LeVee, Maeve A Hennessy, Dame Idossa, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 24, 2026
Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized ApproachDame Idossa, Maeve A Hennessy, Alexis LeVee, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 10, 2026
Advanced Triple-Negative Breast Cancer: Emerging Therapies and a Changing Treatment LandscapeMaeve A Hennessy, Elizabeth Terman, Damé Idossa, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 20, 2021
Prognostic factors influencing survival following re-resection for isocitrate dehydrogenase (IDH) -wildtype glioblastoma multiforme - Data from a national neuro-oncology registryMaeve A Hennessy, Zachary L Coyne, Philip J O'Halloran, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Anti-Cancer Drugs|December 10, 2019
Induction treatment prior to chemoradiotherapy in nasopharyngeal carcinoma: triplet or doublet chemotherapy?Maeve A Hennessy, Patrick G Morris
Annals of Palliative Medicine|April 3, 2020
Optimizing Anti-HER2 Therapy in early breast cancer: updates from the KRISTINE trialMaeve A Hennessy, Patrick G Morris
Irish Journal of Medical Science|April 6, 2024
Dietary supplement beliefs and use patterns among Irish patients with early-stage breast cancerEimear O'Donovan, Maeve A Hennessy, Seamus O'Reilly
Expert Opinion on Investigational Drugs|February 7, 2026
Triple negative breast cancer: what clinical progress have we seen in the last 5 years?Daniel S Peiffer, Maeve A Hennessy, Rita Nanda
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 2, 2024
Charting cancer's course: revealing the role of diet, exercise, and the microbiome in cancer evolution and immunotherapy responseAna Isabel Martin-Quesada, Maeve A Hennessy, Ana Cardeña Gutiérrez
JAMA Network Open|April 23, 2026
Disparities in Disease Presentation and Treatment Initiation for De Novo Metastatic Breast CancerJincong Q Freeman, Apoorva Ravichandran, Sarah Poland, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 16, 2026
Personalizing Curative Therapy in Stage II to III Triple-Negative Breast CancerAlexis LeVee, Maeve A Hennessy, Dame Idossa, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 24, 2026
Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized ApproachDame Idossa, Maeve A Hennessy, Alexis LeVee, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 10, 2026
Advanced Triple-Negative Breast Cancer: Emerging Therapies and a Changing Treatment LandscapeMaeve A Hennessy, Elizabeth Terman, Damé Idossa, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 20, 2021
Prognostic factors influencing survival following re-resection for isocitrate dehydrogenase (IDH) -wildtype glioblastoma multiforme - Data from a national neuro-oncology registryMaeve A Hennessy, Zachary L Coyne, Philip J O'Halloran, et al.
Pageof 2